Skip to main content

Table 7 The promoter methylation status of the P21 and TP53 genes in PE women and control group

From: Analysis of polymorphisms, promoter methylation, and mRNA expression profile of maternal and placental P53 and P21 genes in preeclamptic and normotensive pregnant women

Methylation status

PE

(n = 109)

control

(n = 112)

OR (95% CI)

P-value

BC

P-value

P21 promoter methylation

 UU, n (%)

89 (81.7)

105 (93.8)

1

–

 UM, n (%)

17 (15.6)

7 (6.3)

2.9 (1.1–7.2)

0.026

0.021

 MM, n (%)

3 (2.8)

0 (0)

–

–

 UM + MM vs UU, n (%)

3.4 (1.4–8.3)

0.009

0.006

TP53 promoter methylation

 UU, n (%)

84 (77.1)

102 (91.1)

1

–

 UM, n (%)

17 (15.6)

9 (8)

2.3 (1–5.4)

0.058

0.053

 MM, n (%)

8 (7.3)

1 (0.9)

9.7 (1.2–79.2)

0.034

0.010

 UM + MM vs UU, n (%)

3 (1.4–6.7)

0.006

0.004

  1. U: Unmethylated: M: Methylated; BC P-value, Bonferroni corrected P-value